Wellcome Trust’s JPMorgan Chase JPM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-150,000
Closed -$12.9M 23
2016
Q4
$12.9M Sell
150,000
-600,000
-80% -$45.8M 0.26% 23
2016
Q3
$49.9M Hold
750,000
1.04% 19
2016
Q2
$46.6M Hold
750,000
1.06% 21
2016
Q1
$44.4M Hold
750,000
0.98% 21
2015
Q4
$49.5M Hold
750,000
0.99% 24
2015
Q3
$45.7M Hold
750,000
1.01% 22
2015
Q2
$50.8M Sell
750,000
-10,000
-1% -$653K 1.03% 23
2015
Q1
$46M Hold
760,000
0.99% 22
2014
Q4
$47.6M Hold
760,000
0.98% 24
2014
Q3
$45.8M Buy
760,000
+460,000
+153% +$26.9M 0.95% 25
2014
Q2
$17.3M Sell
300,000
-200,000
-40% -$11.2M 0.42% 27
2014
Q1
$30.4M Buy
500,000
+300,000
+150% +$17.3M 0.75% 24
2013
Q4
$11.7M Buy
+200,000
New +$11M 0.31% 24

Other funds holding JPM

Wellcome Trust's JPM Position: Q3 2022 in Review

Wellcome Trust sold out of JPMorgan Chase (JPM) in Q3 2022, closing a stake of 2,470,000 shares — an estimated $278M sold.

Wellcome Trust first reported a position in JPM in Q2 2013 and held it in 37 quarters. The position peaked at $655M in Q4 2019. 3,391 funds tracked by Wall St. Rank hold JPM as of Q3 2022.

  • Wellcome Trust reported no remaining JPMorgan Chase position as of Q3 2022 after selling out during the quarter.
  • Wellcome Trust sold 2,470,000 JPMorgan Chase shares in Q3 2022, an estimated $278M.
  • Wellcome Trust first reported a position in JPMorgan Chase in Q2 2013 and held it in 37 quarters.
  • Wellcome Trust's JPMorgan Chase position peaked at $655M in Q4 2019.
  • 3,391 funds tracked by Wall St. Rank held JPMorgan Chase as of Q3 2022.

Based on Wellcome Trust's 13F filing for Q3 2022, filed 26 Oct 2022.